Moreover, abnormal coagulation parameters (e.g., prolonged prothrombin time, elevated levels of fibrinogen and D-dimer) and cardiac injury characterized by elevated levels of high sensitive troponin I, myoglobin, and lactic dehydrogenase were recently found to be related to poor outcomes in patients with COVID-19 (10, 22–25). The gene discussed is MB; the disease is COVID-19.